Related Experiment Videos
p53 gene mutation spectrum in human unknown primary tumors
M Bar-Eli1, J L Abbruzzese, D Lee-Jackson
1Department of Cell Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Anticancer Research
|September 1, 1993
Summary
p53 gene mutations are common in many cancers. This study found a 26% mutation rate in unknown primary tumors (UPTs), suggesting p53 mutations may not drive UPT development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mutations in the p53 gene are frequently observed in human cancers.
- Unknown primary tumors (UPTs) are advanced malignancies with poorly understood genetic alterations.
- The role of p53 gene mutations in UPTs remains largely unexplored.
Purpose of the Study:
- To determine the frequency and spectrum of p53 gene mutations in a cohort of unknown primary tumors.
- To assess the potential involvement of p53 alterations in the pathogenesis of UPTs.
Main Methods:
- Analysis of p53 gene mutations in 15 UPT biopsies and 8 UPT cell lines.
- Utilized single-strand conformation polymorphism (SSCP) analysis of p53 exons 5-9.
- Confirmed mutations via direct DNA sequencing of PCR-amplified products.
Main Results:
- A total of 26% (6/23) of UPTs exhibited p53 coding sequence mutations.
- Mutations included point mutations (amino acid change or termination) and frameshift mutations.
- Seven out of eight analyzed tumors showed loss of heterozygosity at the p53 locus.
Conclusions:
- The observed p53 mutation frequency in UPTs is lower than anticipated for advanced metastatic cancers.
- p53 gene mutations may not be a primary driver in the development or progression of unknown primary tumors.
- Further research is needed to elucidate the genetic landscape of UPTs.